BIOVISTA
Biovista is a pioneer of AI and systematic drug repositioning. They apply their systematic discovery Artificial Intelligence platform to develop their pipeline of repositioned drug candidates in disease areas such as neurodegenerative diseases, epilepsy, oncology and orphan diseases. They also work with their collaborators to proactively position and to reposition their own assets, whether new chemical entities or existing compounds. Their scientists use Biovista’s technology platform to ana... lyze massive data resources and identify non-obvious, mechanism-of-action based associations between compounds, molecular targets and diseases. They use this insight to find new uses for existing drugs or drug combinations, assess their risk profile and advance them to PoC and Clinical Phase IIa/b sooner, cheaper and with a higher probability of success than has been possible to date.
BIOVISTA
Industry:
Artificial Intelligence Biotechnology Health Care
Founded:
1999-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.biovista.com
Total Employee:
11+
Status:
Active
Contact:
+1.434.971.1141
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Bigbang Angels
Bigbang Angels is an early stage cross-border accelerator and investor.
Current Employees Featured
Founder
Official Site Inspections
http://www.biovista.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
- Host name: 104.21.34.32
- IP address: 104.21.34.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biovista"
Biovista - Wikipedia
Biovista Inc. is a private drug development services company based in Charlottesville, Virginia, US. Biovista's core business activities include drug repositioning and drug de-risking as well as disease cohort analysis, adverse event prediction and clinical hold analysis services. Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology. See details»
Biovista | Drug Positioning and Prioritization - About us
Biovista - Crunchbase Company Profile & Funding
Biovista is a pioneer of AI and systematic drug repositioning. They apply their systematic discovery Artificial Intelligence platform to develop their pipeline of repositioned drug candidates in disease areas such as neurodegenerative …See details»
Biovista - LinkedIn
Biovista is a proud contributor to the newly published paper: "Building an Adverse Outcome Pathway Network for #COVID19."This international collaborative effort aimed to organize COVID-19 ...See details»
Biovista | Drug Positioning and Prioritization - Contact Us
Sep 15, 2021 Recent Posts. Uberon OBO Contribution May 22, 2024; Navigating the biological unknown April 20, 2023; Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ …See details»
Biovista Company Profile 2024: Valuation, Funding & Investors
Biovista General Information Description. Developer of an artificial intelligence-based biotechnology platform intended to deliver custom drug repositioning, drug de-risking, and …See details»
Biovista - The Org
Biovista is a pioneer of AI and systematic drug repositioning. ... Charlottesville, United States. Employees. 11-50. Links. Org chart. View full screen. Andreas Persidis. CEO. 8 ...See details»
Biovista Company Profile - Office Locations, Competitors ... - Craft
Biovista is a company that provides drug repositioning and de-risking clinical solutions for the biopharma industry. It offers the Project Prodigy platform that enables augmented intelligence, …See details»
Biovista Inc. – A pioneer in AI and systematic drug repositioning
Biovista is one such company that delivers custom drug repositioning, drug de-risking, and clinical hold solutions for the BioPharma Industry. Biovista also develops powerful platform …See details»
Biovista - Company info. interviews, news - BiopharmaTrend
Biovista delivers custom drug repositioning, drug de-risking and clinical hold solutions for the Biopharma Industry. Biovista also develops powerful platform technologies for Life science …See details»
Biovista | Pioneers in Systematic Drug Repositioning
Biovista is developing therapies in multiple sclerosis, mitochondrial diseases, oncology, epilepsy and CFS/ME. Biovista candidates are repositioned drugs presently at the late pre-clinical …See details»
Biovista - Nature
Biovista combines augmented and artificial intelligence to drive new possibilities for safer, more-precise medicines. Anyone who has interacted with an artificial intel- ligence(AI)chatbot ...See details»
Pioneer in Delivering Systematic and Custom Drug Repositioning: …
Biovista's systematic discovery COSS™ platform supports their team of biologists, medical doctors, epidemiologists, and IP experts to generate robust Mechanism-of-Action rationale to …See details»
Biovista - Academic pursuits result in broad perspectives, opening …
Biovista is headed and advised by a unique team who are research leaders and professors holding PhD and MBA degrees from the USA. Another important arm of Biovista is focused on …See details»
Artificial Intelligence firm Biovista repositions four promising ...
CHARLOTTESVILLE, Va., April 22, 2020 /PRNewswire/ -- Biovista, a privately-held AI / bioscience firm best known for drug repositioning, has identified four treatments – two …See details»
Biovista Personalized Medicine and Diginova to deliver next …
Sep 15, 2021 Biovista Personalized Medicine's focus is the delivery of the class-leading AI-Health Shield TM to consumers, patients, caregivers, doctors and health systems.See details»
Biovista | Drug Positioning and Prioritization - Technology
Sep 15, 2021 Biovista’s B2B Services are all backed by a systematic discovery technology platform that is both extremely powerful and flexible. This proprietary platform, called COSS™ …See details»
Drug Positioning and Prioritization - Research - Biovista
Sep 15, 2021 Biovista believes in constant innovation. We have an ongoing R&D program to develop our pipeline, create new and improve existing products and services, and to maintain …See details»
Drug Positioning and Prioritization - Project Prodigy - Biovista
Sep 15, 2021 Project Prodigy is Biovista’s technology platform and long term initiative to develop next generation Augmented Intelligence solutions for the healthcare industry. Including tools …See details»